WAVE Life Sciences Q2 EPS $(0.34) Misses $(0.31) Estimate, Sales $2.272M Miss $7.050M Estimate
WAVE Life Sciences (NASDAQ:WVE) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.31) by 9.68 percent. This is a 9.68 percent decrease over losses of $(0.31) per share
